CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase II, Open-label, Efficacy and Safety Study to Evaluate the Effects of Mogroside Sweetener "PureLo" on Viral Load in Treatment Naïve, Genotype 1 Subjects With Chronic Hepatitis C

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00926120
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:12.959540+00:00
Published At: 2012-02-14T00:00:00+00:00
Record Updated At: 2012-02-14
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Hepatitis C"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2012-02-14"
protocolSection.identificationModule.nctId: "NCT00926120"
protocolSection.identificationModule.officialTitle: "A Phase II, Open-label, Efficacy and Safety Study to Evaluate the Effects of Mogroside Sweetener \"PureLo\" on Viral Load in Treatment Na\u00efve, Genotype 1 Subjects With Chronic Hepatitis C"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.